Argenx’s Potential Blockbuster Gets FDA Nod for Autoimmune Disease
US regulators have approved the first-in-class drug efgartigimod for the treatment of the rare muscle…
US regulators have approved the first-in-class drug efgartigimod for the treatment of the rare muscle…
The EU recently added two drugs to its list of approved Covid-19 treatments. Yet with…
Analysts are abuzz over GSK’s co-development deal with immuno-oncology specialist iTeos Therapeutics earlier this month,…
Scotland has a thriving life sciences ecosystem with strengths in oncology, genetic engineering, and industrial…
A €62M Series B round announced by the Belgian company AgomAb Therapeutics last week is…
A new platform makes automated western blot processing accessible to more labs, freeing up researchers’…
Covid-19 has swept the globe, changing the way we view the world, probably forever. Nearly…
As a wave of Covid-19 infected the crew of a commercial fishing vessel, three sailors…
The Swiss antibody specialist Neurimmune and the German RNA biotech Ethris are collaborating to develop…
French companies OSE Immunotherapeutics and MAbSilico are teaming up to drive the discovery of new…
Alderaan Biotechnology has raised an €18.5M Series A round to push its lead cancer immunotherapy…
4TEEN4 Pharmaceuticals has raised a Series A round of €6.9M to fuel the development of…